New study tracks COVID-19 vaccine side effects in kids ages 5 to 16
NCT ID NCT05157191
First seen Jul 01, 2026 · Last updated Jul 01, 2026
Summary
This study follows children and adolescents aged 5 to 16 who receive an mRNA COVID-19 vaccine to monitor for side effects like injection site pain, fever, and other reactions. Participants report symptoms for a week after each dose, and some provide blood samples to measure antibody levels. The goal is to better understand the safety and immune response of COVID-19 vaccines in younger populations.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mRNA COVID-19 vaccine
What this could lead to
If successful, this study could provide clear safety data on COVID-19 vaccines in children, helping guide vaccination recommendations.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may not apply to all children or vaccine types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centers for Disease Control and Prevention
Atlanta, Georgia, 30333, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Columbia University
New York, New York, 10027, United States
-
Duke University
Durham, North Carolina, 27710, United States
-
Kaiser Permanente Northern California
Oakland, California, 94612, United States